Boston Scientific stock moves after clinical results and index changes Boston Scientific (BSX) has come into focus after ...

Earlier in June 2026, the US Food and Drug Administration posted a Class II, firm-initiated recall of 9,750 Boston Scientific ...

BTIG analysts remain high on Boston Scientific (NYSE:BSX) following meetings with the company's management this week.

DENVER, CO—Final 5-year data from the PROTECT AF and PREVAIL trials of the Watchman left atrial appendage (LAA) closure device (Boston Scientific) continued to show similar overall stroke prevention ...

Boston Scietific's Watchman left atrial appendage closure (LAAC) device won FDA approval in 2015 after an unprecendented three FDA panel reviews. Since then, the Watchman device has become one of the ...

Everybody knows the most important aspect of treating atrial fibrillation is stroke prevention. So far, all we have for this important treatment goal is drugs. Warfarin and now the novel ...